{"nctId":"NCT02307565","briefTitle":"Blood Pressure, Cerebral Blood Flow and Cognition in Spinal Cord Injury","startDateStruct":{"date":"2014-03"},"conditions":["Spinal Cord Injury"],"count":19,"armGroups":[{"label":"Midodrine","type":"EXPERIMENTAL","interventionNames":["Drug: Midodrine","Drug: Placebo"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Midodrine","Drug: Placebo"]}],"interventions":[{"name":"Midodrine","otherNames":["Midodrine or Placebo"]},{"name":"Placebo","otherNames":["Midodrine or Placebo"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\nSpinal Cord Injured\n\n* Between the ages of 18-65 years old.\n* Level of injury is between C1-T12\n* Primarily wheelchair dependent for ambulation\n* Have a spinal cord injury that is ASIA Impairment Scale (AIS) grade of A, B or C\n* Injury occurred more than 1 year ago\n* Low blood pressure (Systolic BP less than 110 mmHg for males, Systolic BP less than 100 mmHg for females)\n* Primary language is English\n* I am right handed\n\nExclusion Criteria:\n\n* Currently have an illness or infection\n* Severe history of AD (more than 3 symptomatic events per week, evidence of blood pressure elevations above 140/90 mmHg,significant adverse subjective symptoms reporting)\n* Hypertension or diabetes\n* History of Traumatic Brain Injury (TBI)\n* Neurological condition other than SCI (Alzheimer's disease, dementia, stroke, multiple sclerosis, Parkinson's disease, etc.)\n* History of epilepsy or other seizure disorder\n* Diagnosis of a psychiatric disorder such as post-traumatic stress disorder, schizophrenia or bipolar disorder\n* Within the past 6 months, abused illicit drugs\n* Pre-screen mini mental status exam score of less than 24, as rated by the researcher\n* Vision is impaired- more than 20/60 in worst eye (with prescription eyewear)\n* Coronary heart and/or artery disease\n* Major surgery in the last 30 days\n* Pregnant","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"65 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Systolic Blood Pressure","description":"Seated systolic blood pressure following midodrine administration compared to placebo.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"116.3","spread":"22.7"},{"groupId":"OG001","value":"98.0","spread":"23.3"}]}]}]},{"type":"SECONDARY","title":"Cerebral Blood Flow","description":"Middle cerebral artery blood flow velocity following midodrine administration compared to placebo.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"45.08","spread":"12.87"},{"groupId":"OG001","value":"43.97","spread":"16.70"}]}]}]},{"type":"SECONDARY","title":"Hopkins Verbal Learning Test","description":"Memory score on the Hopkins Verbal Learning Test following midodrine administration compared to placebo. Higher score is better, range from 0 to 36.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-3.56","spread":"4.16"},{"groupId":"OG001","value":"-2.27","spread":"6.47"}]}]}]},{"type":"SECONDARY","title":"Number of Hypertensive Events","description":"Number of daily systolic blood pressure recordings above 140 mmHg following midodrine administration compared to placebo.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"112","spread":null},{"groupId":"OG001","value":"50","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":19},"commonTop":["Hypertensive response","UTI","Constipation"]}}}